Powerful stories of biotechnology breakthroughs, the people they help, and the global problems they solve.
…
continue reading
Data in Biotech is a fortnightly podcast exploring how companies leverage data to drive innovation in life sciences. Every two weeks, Ross Katz, Principal and Data Science Lead at CorrDyn, sits down with an expert from the world of biotechnology to understand how they use data science to solve technical challenges, streamline operations, and further innovation in their business. You can learn more about CorrDyn - an enterprise data specialist that enables excellent companies to make smarter ...
…
continue reading
From Idea to Action: Stories from Alabama Innovators is a podcast that highlights the people who are driving Alabama forward. We aim to showcase and connect the deep network of innovators, entrepreneurs, policy leaders, and advocates working to make Alabama an even better place. From Idea to Action: Stories from Alabama Innovators is powered by the HudsonAlpha Institute for Biotechnology, a nonprofit organization with a mission to improve the human condition.
…
continue reading
Podcasts from KTH Royal Institute of Technology, Stockholm, Sweden. Interviews on research and innovations from KTH, sometimes with KTH:s partners. Podcasts are produced by the Communications Department at KTH. KTH Royal Institute of Technology in Stockholm, Sweden, is the largest and oldest technical university in Sweden. No less than one third of Sweden’s technical research and engineering education capacity at university level is provided by KTH. Education and research spans from natural ...
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Using Generative AI to Design New Therapeutic Proteins with Evozyne
40:23
40:23
Play later
Play later
Lists
Like
Liked
40:23
This week on Data in Biotech, Ryan Mork, Director of Data Science at Evozyne, joins host Ross Katz to discuss how data science and machine learning are being used in protein engineering and drug discovery. Ryan explains how Evozyne is utilizing large language models (LLMs) and generative AI (GenAI) to design new biomolecules, training the models wi…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
What We Know About the Microbiome (REDUX)
27:25
27:25
Play later
Play later
Lists
Like
Liked
27:25
The gut microbiome, which consists of trillions of bacteria, viruses, and fungi, plays a crucial role in our health. However, there is still much to learn about this complex ecosystem. On this episode we talk with experts who tell us where the science is—how much we know, and how much we don’t. Two companies, Bloom Science and Seres Therapeutics, a…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Balancing Software-Driven Processes and Human Curation to Unlock Genomics Intelligence with Genomenon
40:59
40:59
Play later
Play later
Lists
Like
Liked
40:59
This week on Data in Biotech, Ross is joined by Jonathan Eads, VP of Engineering at genomics intelligence company Genomenon, to discuss how his work supports the company’s mission to make genomic evidence actionable. Jonathan explains his current role leading the teams focused on clinical engineering, curation engineering, platform development and …
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Is CRISPR the New Sickle Cell Savior? (REDUX)
24:39
24:39
Play later
Play later
Lists
Like
Liked
24:39
2023 ended with an exciting biotech breakthrough for sickle cell patients. A gene-editing therapy using the revolutionary CRISPR technology provides new hope and options for the nearly 100,000 Americans with sickle cell disease. In this episode, we talk with the company behind one of the life-changing therapies, CASGEVY, and speak with two advocate…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Optimizing Allogeneic Cell Therapy Manufacturing with Atara Biotherapeutics
40:00
40:00
Play later
Play later
Lists
Like
Liked
40:00
This week on Data in Biotech, we’re joined by Amy Gamber, VP of Manufacturing at Atara Biotherapeutics, an allogeneic T-cell immunotherapy company developing off-the-shelf treatments to help achieve faster patient outcomes. As a treatment that sits at the cutting edge of options available for cancer and autoimmune disease, host Ross Katz explores h…
…
continue reading
It's a holiday week here in the U.S., and the CorrDyn team is currently getting together for our annual company retreat. So, we decided to do something a little different this week. We're re-releasing abridged versions of two of our most popular episodes. These are dedicated to a critical workflow at the intersection of data and scientific research…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Giving Biotech Organizations a ‘Digital Brain’ with Scispot
36:56
36:56
Play later
Play later
Lists
Like
Liked
36:56
This week on Data in Biotech, we’re delighted to be joined by Guru and Satya Singh, co-founders of SciSpot, a company focused on transforming biotech companies through smarter embodiment of biological processes in data/software and acceleration of the R&D process. They discuss how their respective biotech and data backgrounds led them to develop th…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Delivering AI-Driven Drug Development with Generate:Biomedicines
37:00
37:00
Play later
Play later
Lists
Like
Liked
37:00
This week, Ross sits down with Mike Nally, CEO at Generate:Biomedicines, a pioneer in generative biology that is transforming the way medicines are developed. Mike joined the Data in Biotech podcast to discuss the AI-driven drug development landscape and how data is set to change the way every drug is made in the future. Mike shares his journey to …
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Solving Data Integration Challenges in Life Sciences with Ganymede
44:06
44:06
Play later
Play later
Lists
Like
Liked
44:06
This week, Nathan Clark, CEO at Ganymede, joins the Data in Biotech podcast to discuss the challenges of integrating lab instruments and data in the biotech industry and how Ganymede’s developer platform is helping to automate data integration and metadata management across Life Sciences. Nathan sits down with Data in Biotech host Ross Katz to disc…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
The Power of Open-Source Pipelines for Scientific Research with Harshil Patel
41:24
41:24
Play later
Play later
Lists
Like
Liked
41:24
This week, Harshil Patel, Director of Scientific Development at Seqera, joins the Data in Biotech podcast to discuss the importance of collaborative, open-source projects in scientific research and how they support the need for reproducibility. Harshil lifts the lid on how Nextflow has become a leading open-source workflow management tool for scien…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Listener takeover: Your Biotech Questions Answered
21:29
21:29
Play later
Play later
Lists
Like
Liked
21:29
YOU asked, and we answered. In this episode, we had our experts on standby to answer questions from you, our listeners. We discuss topics ranging from the safety of genetically modified foods (GMOs), to the new era of personalized medicine, feeding the world by 2050, and even what makes start-up companies attractive to investors. Follow us on Linke…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Improve Quality and Minimize Variability in Biotech Manufacturing with Stewart Fossceco
38:20
38:20
Play later
Play later
Lists
Like
Liked
38:20
This week, we are pleased to have Stewart Fossceco, Head of Non-Clinical and Diagnostics Statistics at Zoetis and an expert in pharmaceutical manufacturing, join us on the Data in Biotech podcast. We sat down with Stewart to discuss implementing and improving Quality Assurance (QA) processes at every stage of biotech manufacturing, from optimizing …
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Editing Cells Within the Body—a New CRISPR Frontier
21:21
21:21
Play later
Play later
Lists
Like
Liked
21:21
With its potential to expand the horizons of what’s possible for patients, CRISPR is the new darling of biotech. Reaching an important milestone in 2023 with the FDA approval of a sickle cell treatment using CRISPR, the technology is poised to break new barriers for treating patients in the near future. In this episode we talk with two companies wo…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Delivering on the Promise of Electronic Lab Notebooks with SciNote
43:18
43:18
Play later
Play later
Lists
Like
Liked
43:18
This week, we are pleased to welcome to the Data in Biotech podcast Brendan McCorkle, CEO of SciNote, a cloud-based ELN (Electronic Lab Notebook) with lab inventory, compliance, and team management tools. In this episode, we discuss how the priorities of ‘Research’ and ‘Development’ differ when it comes to the data they expect and how they use it, …
…
continue reading
Biotech companies are addressing climate change through innovation—from carbon neutral facilities to agricultural innovations to reduce greenhouse gas emissions. BIO was on the ground at the COP28 UN Climate Change Conference in Dubai to deliver the message that biotech is climate tech. Follow us on LinkedIn, X, Facebook and Instagram. Visit us at …
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Developing Future Sustainable Materials Using AI with Cambrium
39:51
39:51
Play later
Play later
Lists
Like
Liked
39:51
This week, we are pleased to be joined on the Data in Biotech Podcast by Pierre Salvy, who recently became the CTO at Cambrium, and his colleague Lucile Bonnin, Head of Research & Development at Cambrium. As part of the Cambrium team behind NovaColl™, the first micro-molecular and skin-identical vegan collagen to market, Pierre and Lucile share the…
…
continue reading
More than half of U.S. households include pets, but there has been a lack of medical treatments developed specifically for small animals. Biotech companies are working to change that with new treatment options that both borrow from and, potentially, advance human health discoveries. Follow us on LinkedIn, X, Facebook and Instagram. Visit us at http…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Building Strong Data Foundations for Biotech Startups with Jacob Oppenheim
42:05
42:05
Play later
Play later
Lists
Like
Liked
42:05
This week, we are pleased to welcome Jacob Oppenheim, Entrepreneur in Residence at Digitalis Ventures, a venture capital firm that invests in solutions to complex problems in human and animal health. Jacob sat down with Ross to discuss the importance of establishing strong data foundations in biotech companies and how to approach the task. We explo…
…
continue reading
The gut microbiome, which consists of trillions of bacteria, viruses, and fungi, plays a crucial role in our health. However, there is still much to learn about this complex ecosystem. On this episode we talk with experts who tell us where the science is—how much we know, and how much we don’t. Two companies, Bloom Science and Seres Therapeutics, a…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
How OmicSoft Is Facilitating In-Depth Exploration Among NGS Datasets
34:44
34:44
Play later
Play later
Lists
Like
Liked
34:44
This week's guest is Joseph Pearson, Global Product Manager of OmicSoft at QIAGEN, a global provider of sample-to-insight solutions that enable customers to gain valuable molecular insights. During this episode, we dive into OmicSoft, a powerful NGS analysis suite that can quickly explore and compare 500,000 curated omics samples from disease-relat…
…
continue reading
2023 ended with an exciting biotech breakthrough for sickle cell patients. A gene-editing therapy using the revolutionary CRISPR technology provides new hope and options for the nearly 100,000 Americans with sickle cell disease. In this episode, we talk with the company behind one of the life-changing therapies, CASGEVY, and speak with two advocate…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
How Bayesian Optimization is Helping to Accelerate Innovation at Merck Group
39:13
39:13
Play later
Play later
Lists
Like
Liked
39:13
This week's guest is Wolfgang Halter, Head of Data Science and Bioinformatics at Merck Life Science, a leading global science and technology company. Ross sat down with Wolfgang to discuss the work on the BayBE project, an open-source library built for Bayesian optimization. Throughout the episode, we go on to learn how BayBE is used for both exper…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
“On My Own”—Desperate to Stop a Resistant Bacterial Infection (REDUX)
27:42
27:42
Play later
Play later
Lists
Like
Liked
27:42
Bradley Burnam woke up one morning, looked in the mirror and found one ear twice it’s normal size and his face swollen and discolored. He would spend the next several years in and out of the hospital fighting a relentless infection that would not respond to available treatments. The experience took him from patient to mad scientist, to biotech comp…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Transforming Care for Neurological Disorders Through Artificial Intelligence with Annemie Ribbens
48:28
48:28
Play later
Play later
Lists
Like
Liked
48:28
This week, we’re delighted to be joined by Annemie Ribbens, VP Science, Evidence and Trials at icometrix, a medical technology manufacturer that offers a portfolio of AI solutions to assist healthcare with various challenges in neurological disorders, such as brain trauma, strokes, dementia, and Alzheimer's disease. During this episode, Annemie ope…
…
continue reading
Innovative companies are using synthetic biology to engineer organisms and create new materials that could transform every sector of our economy, from health care to food and energy production. Those companies say we’ve entered a synbio revolution, and it holds potential to improve the health of people and our planet. In this episode, we talk with …
…
continue reading
![Artwork](/static/images/128pixel.png)
1
The Applications of Real-World Data in Biotech with Lana Denysyk
34:43
34:43
Play later
Play later
Lists
Like
Liked
34:43
This week, we’re delighted to be joined by Lana Denysyk, Head of RWD Assets at Novo Nordisk. During this conversation, Lana shares how real-world data is used in biotech, diving into how it can help clinicians understand patient experiences outside clinical trials. Lana also discusses the challenges in acquiring and utilising real-world data, the i…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
How Biotechs Survive the Valley of Death (REDUX)
25:05
25:05
Play later
Play later
Lists
Like
Liked
25:05
For biotech companies, the valley of death describes the difficult path from initial discovery to FDA approval and commercialization. It's a treacherous journey—one that even promising innovations often don't complete. Adequate funding, regulatory hurdles and the immense complexity of the biotech landscape are among the never-ending challenges face…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
The Role of Knowledge Graphs in Biopharma with Cody Schiffer
41:03
41:03
Play later
Play later
Lists
Like
Liked
41:03
This week, we’re delighted to be joined by Cody Schiffer, Associate Director, Machine Learning at SMPA - a biopharmaceutical company focused on delivering therapeutic and scientific breakthroughs in areas of critical patient need, During this conversation, Cody and Ross discuss the construction, maintenance, and application of a knowledge graphic i…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Biotech Women Striking at the Glass Ceiling (REDUX)
24:38
24:38
Play later
Play later
Lists
Like
Liked
24:38
The biotech industry offers unique opportunities for women to advance as executives and entrepreneurs. There are headwinds, however, including unequal access to venture capital. In this episode, we talk with three executives who are part of a wave of women-led companies in biotech. Our guests speak to why women’s leadership matters and the barriers…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Overcoming Data Fragmentation in Healthcare with Vera Mucaj
45:54
45:54
Play later
Play later
Lists
Like
Liked
45:54
This week, we’re delighted to be joined by Vera Mucaj, Chief Scientific Officer at Datavant, a data logistics company for healthcare. During the interview, Vera shares how the organization helps companies overcome issues of data fragmentation and availability, which ultimately leads to better decision-making in healthcare, the importance of connect…
…
continue reading
Bees and other pollinators are critical to our survival, with one out of every three bites of food we eat depending on pollination to produce. That’s why reports of a decline in bee populations and rising threats from pests, viruses and environmental pressures, including climate change, are alarming. In this episode we talk with an expert on bees a…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Machine Learning and Quality Control in Biotech Manufacturing with James Winegar
29:27
29:27
Play later
Play later
Lists
Like
Liked
29:27
Data in Biotech is a fortnightly podcast exploring how companies leverage data innovation in life sciences. This week, we’re delighted to be joined by James Winegar, CEO of CorrDyn, a data-driven technology consultancy that helps some of the largest biotechnology manufacturers in the US make smarter strategic decisions by unlocking the value of the…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
The Horseshoe Crab Saved Us. Can We Save the Horseshoe Crab? (REDUX)
28:02
28:02
Play later
Play later
Lists
Like
Liked
28:02
The horseshoe crab has endured for over 450 million years. It has survived several mass extinctions including the one that killed off the dinosaurs. One reason for their incredible resiliency is their ability to fend off bacterial infection. Their blood contains cells that clot around invading bacteria, thereby protecting them from the attacking to…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Solving Reproducibility Challenges in Biotech with Harry Rickerby
41:47
41:47
Play later
Play later
Lists
Like
Liked
41:47
Data in Biotech is a fortnightly podcast exploring how companies leverage data innovation in life sciences. This week, we’re delighted to be joined by Harry Rickerby, Co-founder of Briefly Bio, a groundbreaking platform he's developing to streamline experimental design in life sciences using large language models (LLMs). Host Ross Katz speaks with …
…
continue reading
![Artwork](/static/images/128pixel.png)
1
“On My Own”—Desperate to Stop a Resistant Bacterial Infection
27:42
27:42
Play later
Play later
Lists
Like
Liked
27:42
Bradley Burnam woke up one morning, looked in the mirror and found one ear twice it’s normal size and his face swollen and discolored. He would spend the next several years in and out of the hospital fighting a relentless infection that would not respond to available treatments. The experience took him from patient to "mad scientist" to biotech com…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Jesse Johnson on Bridging the Data Gap in Biotech Startups
42:47
42:47
Play later
Play later
Lists
Like
Liked
42:47
Data in Biotech is a fortnightly podcast exploring how companies leverage data innovation in life sciences. This week, we’re delighted to be joined by Jesse Johnson, Founder of Merelogic, a consultancy service for biotech startups who want to get their data under control so they can focus on the science. Host Ross Katz speaks with Jesse about the i…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Episode 19: Bill Poole and Cynthia Crutchfield
51:02
51:02
Play later
Play later
Lists
Like
Liked
51:02
This episode features Bill Poole, Finance Director for the State of Alabama, and Cynthia Crutchfield, CEO of Innovate Alabama. These two Alabama leaders discuss how the State and Innovate Alabama support entrepreneurs, businesses, and commercialization. They share about the history of the Innovation Commission that kicked off new resources for Alab…
…
continue reading
Follow us on LinkedIn, X, Facebook and Instagram. Visit us at https://www.bio.org/ Innovative companies are using synthetic biology to engineer organisms and create new materials that could transform every sector of our economy, from health care to food and energy production. Those companies say we’ve entered a synbio revolution, and it holds poten…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Tommy Tang on Building a Dry Lab Team, Selecting the Right Tools, and When to Use ML in Bioinformatics
45:11
45:11
Play later
Play later
Lists
Like
Liked
45:11
Data in Biotech is a fortnightly podcast exploring how companies leverage data to drive innovation in life sciences. This week, we're delighted to be joined by Tommy Tang, Director of Computational Biology at Immunitas Therapeutics - an immuno-oncology therapeutics company advancing multiple programs to the clinic. Host Ross Katz speaks with Ming “…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Episode 18: Todd Greer with Innovation Portal in Mobile, AL
44:36
44:36
Play later
Play later
Lists
Like
Liked
44:36
In this episode, we sit down with Todd Greer, Executive Director of Innovation Portal, a nonprofit incubator and innovation hub accelerating startup growth in the Gulf Coast Region. We discuss how to support small businesses and what it takes to nurture economic growth and draw similarities between Mobile and the other major cities across Alabama. …
…
continue reading
Follow us on LinkedIn, X, Facebook and Instagram. Visit us at https://www.bio.org/ For biotech companies, the valley of death describes the difficult path from initial discovery to FDA approval and commercialization. It's a treacherous journey—one that even promising innovations often don't complete. Adequate funding, regulatory hurdles and the imm…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
The Future of Clinical Trials: How Data, AI and ML Will Improve Healthcare with Miguel Cacho Soblechero
36:45
36:45
Play later
Play later
Lists
Like
Liked
36:45
Data in Biotech is a fortnightly podcast exploring how companies leverage data to drive innovation in life sciences. This week, we're delighted to be joined by Miguel Cacho Soblechero, Ph.D., a senior data scientist at Prolaio - a biotech company that integrates clinical research and data science to improve research, access and outcomes for people …
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Episode 17: Sean Powers with The University of South Alabama
39:12
39:12
Play later
Play later
Lists
Like
Liked
39:12
Description: In this episode, we sit down to talk with Sean Powers, PhD, Angelia and Steven Stokes Endowed Professor in Environmental Resiliency and Director, Stokes School of Marine Sciences, University of South Alabama. Over the course of this episode, we talk about his journey to Alabama and how Gulf Coast research and global fishery research in…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Biotech Women Striking at the Glass Ceiling
24:38
24:38
Play later
Play later
Lists
Like
Liked
24:38
Follow us on LinkedIn, X, Facebook and Instagram. Visit us at https://www.bio.org/ The biotech industry offers unique opportunities for women to advance as executives and entrepreneurs. There are headwinds, however, including unequal access to venture capital. In this episode, we talk with three executives who are part of a wave of women-led compan…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Episode 16: President Jo Bonner with The University of South Alabama
54:31
54:31
Play later
Play later
Lists
Like
Liked
54:31
In this episode, we sit down to talk with Jo Bonner, President of the University of South Alabama in Mobile, AL. We discuss President Bonner’s unique background and his goal to leverage South Alabama’s unique environment to attract talent, carve out a unique space in the academic landscape, and make a profound impact on the state and beyond. Dig in…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Data Science and Diagnostic Models - the What, Why and How with Michelle Wiest
44:05
44:05
Play later
Play later
Lists
Like
Liked
44:05
This week, we're delighted to be joined by Michelle Wiest, Director of IVD Biostatistics at Freenome - a high-growth biotech company that creates tools to help prevent, detect, and treat disease. Host Ross Katz speaks with Michelle on the use of biostatistics in the field of diagnostics, what biases can corrupt diagnostic tests and how to catch the…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Markus Gershater on Why Experimental Design in Biotech is Broken and How to Fix It
41:09
41:09
Play later
Play later
Lists
Like
Liked
41:09
This week, we're delighted to be joined by Markus Gershater, Chief Scientific Officer and CoFounder of Synthace - a digital experiment platform built for high-performance life science R&D teams to help them run more powerful experiments and accelerate scientific progress. Host Ross Katz speaks with Markus on what’s broken about: What’s broken about…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Fighting Cancer with Data Science and CAR-T Therapies with Pradeep Ravindra
39:12
39:12
Play later
Play later
Lists
Like
Liked
39:12
This week we’re excited to be joined by Pradeep Ravindra, Associate Director, Data Analytics, Manufacturing from Lyell Immunopharma. He shares his story on transitioning from military intelligence to life sciences analytics, the role of data analytics in manufacturing and delivering CAR-T therapies, and how to foster a culture of data-driven decisi…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Welcome to Data in Biotech - a CorrDyn Podcast
0:49
0:49
Play later
Play later
Lists
Like
Liked
0:49
Welcome to Data in Biotech, a podcast from CorrDyn where we explore how companies leverage data to drive innovation in life sciences. In each episode, our host Ross Katz, sits down with an expert from the world of biotechnology to understand how they use data science to solve technical challenges, streamline operations, and further innovation in li…
…
continue reading
Follow us on LinkedIn, X, Facebook and Instagram. Visit us at https://www.bio.org/ Bees and other pollinators are critical to our survival, with one out of every three bites of food we eat depending on pollination to produce. That’s why reports of a decline in bee populations and rising threats from pests, viruses and environmental pressures, inclu…
…
continue reading